Theravance Biopharma Up Over 10%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk

Dow Jones

Nov 14, 2024

Theravance Biopharma Inc $(TBPH)$ is currently at $9.85, up $0.94 or 10.49%

--Would be highest close since Aug. 1, 2024, when it closed at $10.03

--On pace for largest percent increase since Jan. 3, 2022, when it rose 11.13%

--Currently up six of the past seven days

--Up 19.48% month-to-date

--Down 12.41% year-to-date; on pace for worst year since 2021, when it fell 37.82%

--Down 76.87% from its all-time closing high of $42.56 on July 7, 2017

--Down 3.76% from 52 weeks ago (Nov. 15, 2023), when it closed at $10.23

--Down 15.06% from its 52-week closing high of $11.59 on Jan. 3, 2024

--Up 28.52% from its 52-week closing low of $7.66 on Aug. 9, 2024

--Traded as high as $10.26; highest intraday level since July 31, 2024, when it hit $10.35

--Up 15.15% at today's intraday high; largest intraday percent increase since April 12, 2024, when it rose as much as 16.91%

All data as of 11:53:04 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 13, 2024 11:56 ET (16:56 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2483883154"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483883154\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2483883154?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-14 00:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483883154","market":"hk","top_or_hot":-1,"title":"Theravance Biopharma Up Over 10%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Theravance Biopharma Inc <a href=\"https://laohu8.com/S/TBPH\">$(TBPH)$</a> is currently at $9.85, up $0.94 or 10.49% \n</p>\n<pre>\n \n</pre>\n<p>\n     --Would be highest close since Aug. 1, 2024, when it closed at $10.03 \n</p>\n<p>\n     --On pace for largest percent increase since Jan. 3, 2022, when it rose 11.13% \n</p>\n<p>\n     --Currently up six of the past seven days \n</p>\n<p>\n     --Up 19.48% month-to-date \n</p>\n<p>\n     --Down 12.41% year-to-date; on pace for worst year since 2021, when it fell 37.82% \n</p>\n<p>\n     --Down 76.87% from its all-time closing high of $42.56 on July 7, 2017 \n</p>\n<p>\n     --Down 3.76% from 52 weeks ago (Nov. 15, 2023), when it closed at $10.23 \n</p>\n<p>\n     --Down 15.06% from its 52-week closing high of $11.59 on Jan. 3, 2024 \n</p>\n<p>\n     --Up 28.52% from its 52-week closing low of $7.66 on Aug. 9, 2024 \n</p>\n<p>\n     --Traded as high as $10.26; highest intraday level since July 31, 2024, when it hit $10.35 \n</p>\n<p>\n     --Up 15.15% at today's intraday high; largest intraday percent increase since April 12, 2024, when it rose as much as 16.91% \n</p>\n<pre>\n \n</pre>\n<p>\n     All data as of 11:53:04 AM ET \n</p>\n<pre>\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2024 11:56 ET (16:56 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Theravance Biopharma Up Over 10%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTheravance Biopharma Up Over 10%, on Pace for Largest Percent Increase Since January 2022 -- Data Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-11-14 00:56</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Theravance Biopharma Inc <a href=\"https://laohu8.com/S/TBPH\">$(TBPH)$</a> is currently at $9.85, up $0.94 or 10.49% \n</p>\n<pre>\n \n</pre>\n<p>\n     --Would be highest close since Aug. 1, 2024, when it closed at $10.03 \n</p>\n<p>\n     --On pace for largest percent increase since Jan. 3, 2022, when it rose 11.13% \n</p>\n<p>\n     --Currently up six of the past seven days \n</p>\n<p>\n     --Up 19.48% month-to-date \n</p>\n<p>\n     --Down 12.41% year-to-date; on pace for worst year since 2021, when it fell 37.82% \n</p>\n<p>\n     --Down 76.87% from its all-time closing high of $42.56 on July 7, 2017 \n</p>\n<p>\n     --Down 3.76% from 52 weeks ago (Nov. 15, 2023), when it closed at $10.23 \n</p>\n<p>\n     --Down 15.06% from its 52-week closing high of $11.59 on Jan. 3, 2024 \n</p>\n<p>\n     --Up 28.52% from its 52-week closing low of $7.66 on Aug. 9, 2024 \n</p>\n<p>\n     --Traded as high as $10.26; highest intraday level since July 31, 2024, when it hit $10.35 \n</p>\n<p>\n     --Up 15.15% at today's intraday high; largest intraday percent increase since April 12, 2024, when it rose as much as 16.91% \n</p>\n<pre>\n \n</pre>\n<p>\n     All data as of 11:53:04 AM ET \n</p>\n<pre>\n \n</pre>\n<p>\n     Source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2024 11:56 ET (16:56 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TBPH","symbol_name":"Theravance Biopharma Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483883154","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483883154","pubTimestamp":1731516960,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Theravance Biopharma Inc  is currently at $9.85, up $0.94 or 10.49%. --Would be highest close since Aug. 1, 2024, when it closed at $10.03. --On pace for largest percent increase since Jan. 3, 2022, when it rose 11.13%. --Down 12.41% year-to-date; on pace for worst year since 2021, when it fell 37.82%. --Down 76.87% from its all-time closing high of $42.56 on July 7, 2017. --Down 3.76% from 52 weeks ago , when it closed at $10.23. --Down 15.06% from its 52-week closing high of $11.59 on Jan. 3, 2024. --Traded as high as $10.26; highest intraday level since July 31, 2024, when it hit $10.35. --Up 15.15% at today's intraday high; largest intraday percent increase since April 12, 2024, when it rose as much as 16.91%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TBPH":"Theravance Biopharma Inc.","BK4007":"制药"},"translate_title":"Theravance Biopharma上涨超过10%，有望创2022年1月以来最大百分比涨幅——Data Talk","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TBPH":1},"content_text":"Theravance Biopharma Inc $(TBPH)$ is currently at $9.85, up $0.94 or 10.49% \n\n\n \n\n\n     --Would be highest close since Aug. 1, 2024, when it closed at $10.03 \n\n\n     --On pace for largest percent increase since Jan. 3, 2022, when it rose 11.13% \n\n\n     --Currently up six of the past seven days \n\n\n     --Up 19.48% month-to-date \n\n\n     --Down 12.41% year-to-date; on pace for worst year since 2021, when it fell 37.82% \n\n\n     --Down 76.87% from its all-time closing high of $42.56 on July 7, 2017 \n\n\n     --Down 3.76% from 52 weeks ago (Nov. 15, 2023), when it closed at $10.23 \n\n\n     --Down 15.06% from its 52-week closing high of $11.59 on Jan. 3, 2024 \n\n\n     --Up 28.52% from its 52-week closing low of $7.66 on Aug. 9, 2024 \n\n\n     --Traded as high as $10.26; highest intraday level since July 31, 2024, when it hit $10.35 \n\n\n     --Up 15.15% at today's intraday high; largest intraday percent increase since April 12, 2024, when it rose as much as 16.91% \n\n\n \n\n\n     All data as of 11:53:04 AM ET \n\n\n \n\n\n     Source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 11:56 ET (16:56 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}